Brief: Century Therapeutics Entered Into Sales Agreement With Cowen And Company
July 1 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS - ON JULY 1, 2022, CO ENTERED INTO
SALES
AGREEMENT WITH COWEN AND COMPANY, LLC - SEC FILING
* CENTURY THERAPEUTICS - UNDER DEAL CO MAY OFFER AND SELL
SHARES
OF COMMON STOCK OF UP TO $150 MILLION
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview